BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6210206)

  • 21. Studies on the use of nonhuman primates to determine the DR status of the human hematopoietic stem cell.
    Winton EF; Colenda KW; McClure HM; Chan WC; Gordon DS
    Exp Hematol; 1985 Oct; 13(9):869-73. PubMed ID: 3862599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Kinetics of the appearance of HLA-DR antigens on human alloactivated T lymphocytes and the demonstration of new antigenic determinants].
    Wollman EE; Lepage V; Delima M; Fradelizi D; Degos L; Dausset J
    C R Seances Acad Sci D; 1980 Nov; 291(9):757-61. PubMed ID: 6162584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostaglandin-E-mediated modulation of human marrow CFU-GM Ia-antigen expression: kinetics and specificity.
    Pelus LM
    Exp Hematol; 1984 Dec; 12(11):831-7. PubMed ID: 6210207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional activities of acidic isoferritins and lactoferrin in vitro and in vivo.
    Broxmeyer HE; Gentile P; Cooper S; Lu L; Juliano L; Piacibello W; Meyers PA; Cavanna F
    Blood Cells; 1984; 10(2-3):397-426. PubMed ID: 6543656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of cell cycle expression of Ia-like antigenic determinations on normal human multipotential (CFU-GEMM) and erythroid (BFU-E) progenitor cells with regulation in vitro by acidic isoferritins.
    Lu L; Broxmeyer HE; Meyers PA; Moore MA; Thaler HT
    Blood; 1983 Feb; 61(2):250-6. PubMed ID: 6185165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement sensitivity of erythroid and myeloid precursors in paroxysmal in nocturnal hemoglobinuria.
    Ishida Y; Matsumoto N; Shinohara K; Yamada K; Inoue M; Kaneko T; Murphy MJ
    Int J Cell Cloning; 1984 Sep; 2(5):316-26. PubMed ID: 6491393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigenic characteristics of circulating CFU-GM in chronic granulocytic leukaemia resemble those of CFU-GM in normal marrow and differ from those in normal blood.
    Robak T; Nolasco I; Hibbin J; Goldman JM
    Leuk Res; 1985; 9(8):1023-9. PubMed ID: 2413317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-class II antigens on human hematopoietic progenitors.
    Busch FW; Langer M; Pawelec G; Ziegler A; Wernet P; Bühring HJ; Meyer P; Müller C
    Blut; 1987 Mar; 54(3):179-88. PubMed ID: 2434163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between HLA-DR expression by normal myeloid progenitor cells and inhibition of colony growth by prostaglandin E. Implications for prostaglandin E resistance in chronic myeloid leukemia.
    Cannistra SA; Herrmann F; Davis R; Nichols K; Griffin JD
    J Clin Invest; 1986 Jan; 77(1):13-20. PubMed ID: 3455931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenic characteristics of erythropoietin dependent and independent erythroid progenitors (BFU-E and CFU-E) in polycythaemia vera and idiopathic myelofibrosis defined by monoclonal antibodies.
    Robak T
    Arch Immunol Ther Exp (Warsz); 1988; 36(6):733-47. PubMed ID: 3254121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-HEL cell monoclonal antibodies recognize determinants that are also present in hemopoietic progenitors.
    Papayannopoulou T; Brice M; Yokochi T; Rabinovitch PS; Lindsley D; Stamatoyannopoulos G
    Blood; 1984 Feb; 63(2):326-34. PubMed ID: 6198012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective expression of class-II MHC antigens during hemopoietic differentiation.
    Katz FE; Davis L; Myers CD; Greaves MF
    Exp Hematol; 1985 Dec; 13(11):1182-7. PubMed ID: 3864642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture.
    Simmons PJ; Aylett GW; Niutta S; To LB; Juttner CA; Ashman LK
    Exp Hematol; 1994 Feb; 22(2):157-65. PubMed ID: 7507857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA-DR epitope region definition by use of monoclonal antibody probes.
    Grumet FC; Charron DJ; Fendly BM; Levy R; Ness DB
    J Immunol; 1980 Dec; 125(6):2785-9. PubMed ID: 6159421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of the proliferation of human marrow erythroid (BFU-E) progenitor cells by prostaglandin E requires the participation of OKT8-positive T lymphocytes and is associated with the density expression of major histocompatibility complex class II antigens on BFU-E.
    Lu L; Pelus LM; Broxmeyer HE; Moore MA; Wachter M; Walker D; Platzer E
    Blood; 1986 Jul; 68(1):126-33. PubMed ID: 3487351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-HLA-A, B, C and DR antibodies in renal transplant recipients.
    Akiyama N; Kusaba R; Osawa N; Inou T; Kawamura A
    Jpn J Exp Med; 1980 Jun; 50(3):205-11. PubMed ID: 7001096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surface antigenic determinants on human pluripotent and unipotent hematopoietic progenitor cells.
    Bodger MP; Izaguirre CA; Blacklock HA; Hoffbrand AV
    Blood; 1983 May; 61(5):1006-10. PubMed ID: 6187396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-mediated lysis of human hematopoietic progenitor cells.
    Voogt PJ; Fibbe WE; Veenhof WF; Brand A; Goulmy E; van Rood JJ; Falkenburg JH
    Leukemia; 1987 May; 1(5):427-31. PubMed ID: 3499546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human erythroid progenitor cells express Rhesus antigens.
    Falkenburg JH; Fibbe WE; van der Vaart-Duinkerken N; Nichols ME; Rubinstein P; Jansen J
    Blood; 1985 Sep; 66(3):660-3. PubMed ID: 3928000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship of cell-cycle expression of Ia-like antigenic determinants on normal and leukemia human granulocyte-macrophage progenitor cells to regulation in vitro by acidic isoferritins.
    Broxmeyer HE
    J Clin Invest; 1982 Mar; 69(3):632-42. PubMed ID: 6174548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.